Charles City, IA, United States of America

Margus Eek

This inventor holds 1 USPTO granted patent. Top assignee: Cambrex Charles City, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margus Eek. Retrieved from https://idiyas.com/inventor/margus-eek-k1aqz911

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Margus Eek: Innovator in Pharmaceutical Chemistry

Introduction

Margus Eek is a notable inventor based in Charles City, Iowa, recognized for his contributions to pharmaceutical chemistry. He has developed innovative methods that enhance the preparation of important compounds used in medicine.

Latest Patents

Margus Eek holds a patent for "Methods of O-demethylation." This patent describes a novel process for preparing a compound of formula I, where R, R, W, and Z are defined in the description. The process involves the demethylation of a corresponding O-methyl derivative using a borohydride-based reagent. This method is particularly significant in the preparation of buprenorphine, a medication used to treat opioid addiction and pain.

Career Highlights

Margus Eek is currently employed at Cambrex Charles City, Inc., where he applies his expertise in chemical processes to develop pharmaceutical solutions. His work has contributed to advancements in drug formulation and production.

Collaborations

Margus collaborates with talented professionals in his field, including Par Holmberg and Lars Eklund. These partnerships enhance the innovative capacity of their projects and contribute to the success of their research endeavors.

Conclusion

Margus Eek's work in pharmaceutical chemistry exemplifies the impact of innovation on healthcare. His patented methods and collaborations continue to advance the field, making significant contributions to medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…